Takeda R&D chief Andy Plump to retire in 2027 as Novo Nordisk names Alex Hoffman global research head

Takeda announced that its head of research and development, Andy Plump, will step down in June 2027. Plump, who joined Takeda from Sanofi in 2015 and has led R&D since December 2018, will retire after more than a decade with the company.

The announcement comes as Takeda recently celebrated two FDA approvals, highlighting ongoing progress in its pipeline. The retiree’s departure will trigger a search for a successor to guide future R&D strategy.

Meanwhile, Novo Nordisk disclosed that Alex Hoffman has been appointed as its new global research head, signaling a leadership refresh at the Danish drugmaker.